TMO logo

Thermo Fisher Scientific Inc. Stock Price

NYSE:TMO Community·US$203.6b Market Cap
  • 4 Narratives written by author
  • 0 Comments on narratives written by author
  • 191 Fair Values set on narratives written by author

TMO Share Price Performance

US$536.19
-63.06 (-10.52%)
1.9% undervalued intrinsic discount
US$546.76
Fair Value
US$536.19
-63.06 (-10.52%)
1.9% undervalued intrinsic discount
US$546.76
Fair Value
Price US$536.19
AnalystConsensusTarget US$546.76
Unike US$540.27
AnalystLowTarget US$450.00

TMO Community Narratives

AnalystConsensusTarget·
Fair Value US$546.76 1.9% undervalued intrinsic discount

Pharmaceutical And Biotech Expansion Will Fuel Future Success

0users have liked this narrative
0users have commented on this narrative
69users have followed this narrative
Unike·
Fair Value US$540.27 0.8% undervalued intrinsic discount

The demand for personalized medicine will keep Thermo Fisher Scientific thriving

0users have liked this narrative
0users have commented on this narrative
22users have followed this narrative
AnalystLowTarget·
Fair Value US$450 19.2% overvalued intrinsic discount

US China Tensions And Trade Restrictions Will Impair Margins

0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative

Recent TMO News & Updates

Thermo Fisher Scientific Inc. Key Details

US$43.2b

Revenue

US$25.4b

Cost of Revenue

US$17.8b

Gross Profit

US$11.3b

Other Expenses

US$6.6b

Earnings

Last Reported Earnings
Jun 28, 2025
Next Reporting Earnings
Oct 22, 2025
Earnings per share (EPS)
17.44
Gross Margin
41.28%
Net Profit Margin
15.24%
Debt/Equity Ratio
69.2%

Thermo Fisher Scientific Inc. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Proven track record and fair value.

1 Risk
3 Rewards

About TMO

Founded
1956
Employees
125000
CEO
Marc Casper
WebsiteView website
www.thermofisher.com

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, as well as diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company’s Specialty Diagnostics segment includes clinical diagnostics offering liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics offers develops, manufactures, and markets complete blood test systems to support the clinical diagnosis and monitoring of allergy, asthma, and autoimmune diseases; microbiology offers dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; transplant diagnostics products include human leukocyte antigen typing and testing for organ transplant market; and healthcare market channel offers consumables, diagnostic kits and reagents, equipment, instruments, solutions, and services. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Market Insight

Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading

U.S. Market Performance

  • 7 Days: 0.4%
  • 3 Months: 7.8%
  • 1 Year: 17.8%
  • Year to Date: 14.7%
The Healthcare sector gained 3.7% while the market remained flat over the last week. As for the longer term, the market has risen 18% in the past 12 months. Earnings are forecast to grow by 15% annually. Market details ›